Interestingly, the single most commonly comutated gene with TP53 was TET2, with 12% of patients with TP53-mutant AML having a coexisting TET2 mutation (Figure 1A and Supplemental Figure 1B). The gene discussed is TET2; the disease is acute myeloid leukemia.